These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

558 related items for PubMed ID: 12837120

  • 21. The efficacy and safety of QVAR (hydrofluoroalkane-beclometasone diproprionate extrafine aerosol) in asthma (Part 2): Clinical experience in children.
    van Schayck CP, Donnell D.
    Int J Clin Pract; 2004 Aug; 58(8):786-94. PubMed ID: 15372852
    [Abstract] [Full Text] [Related]

  • 22. Asthma control with extrafine-particle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon-beclometasone: a real-world observational study.
    Barnes N, Price D, Colice G, Chisholm A, Dorinsky P, Hillyer EV, Burden A, Lee AJ, Martin RJ, Roche N, von Ziegenweidt J, Israel E.
    Clin Exp Allergy; 2011 Nov; 41(11):1521-32. PubMed ID: 21752116
    [Abstract] [Full Text] [Related]

  • 23. Evaluation of tests of hypothalamic-pituitary-adrenal axis function used to measure effects of inhaled corticosteroids.
    Bernstein DI, Allen DB.
    Ann Allergy Asthma Immunol; 2007 Feb; 98(2):118-27. PubMed ID: 17304877
    [Abstract] [Full Text] [Related]

  • 24. Inhaled corticosteroids reduce growth. Or do they?
    Brand PL.
    Eur Respir J; 2001 Feb; 17(2):287-94. PubMed ID: 11334133
    [Abstract] [Full Text] [Related]

  • 25. [Influence of inhaled glucocorticoids on bone mineral density and bone metabolism].
    Saraví FD, Guirao MA, Elías PC, Guarnieri PJ.
    Rev Panam Salud Publica; 2000 Apr; 7(4):211-8. PubMed ID: 10846923
    [Abstract] [Full Text] [Related]

  • 26. Systemic effects of inhaled corticosteroids on growth and bone turnover in childhood asthma: a comparison of fluticasone with beclomethasone.
    Rao R, Gregson RK, Jones AC, Miles EA, Campbell MJ, Warner JO.
    Eur Respir J; 1999 Jan; 13(1):87-94. PubMed ID: 10836329
    [Abstract] [Full Text] [Related]

  • 27. Fluticasone propionate powder and lack of clinically significant effects on hypothalamic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma.
    Li JT, Ford LB, Chervinsky P, Weisberg SC, Kellerman DJ, Faulkner KG, Herje NE, Hamedani A, Harding SM, Shah T.
    J Allergy Clin Immunol; 1999 Jun; 103(6):1062-8. PubMed ID: 10359887
    [Abstract] [Full Text] [Related]

  • 28. The efficacy and safety of QVAR (hydrofluoroalkane-beclometasone diproprionate extrafine aerosol) in asthma (part 1): an update of clinical experience in adults.
    Van Schayck CP, Donnell D.
    Int J Clin Pract; 2004 Jul; 58(7):678-88. PubMed ID: 15311725
    [Abstract] [Full Text] [Related]

  • 29. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part I. Mechanisms of actions and clinical effectiveness of treatment in children with asthma].
    Bartkowiak-Emeryk M, Breborowicz A, Emeryk A, Kulus M, Kurzawa R, Lis G, Mazurek H, Niedziela M.
    Pol Merkur Lekarski; 2004 Jul; 17 Suppl 2():5-10. PubMed ID: 15688663
    [Abstract] [Full Text] [Related]

  • 30. Effect of long term inhaled corticosteroid therapy on adrenal suppression, growth and bone health in children with asthma.
    Kwda A, Gldc P, Baui B, Kasr K, Us H, S W, Kantha L, Ksh S.
    BMC Pediatr; 2019 Nov 05; 19(1):411. PubMed ID: 31684902
    [Abstract] [Full Text] [Related]

  • 31. Inhaled fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma.
    Holliday SM, Faulds D, Sorkin EM.
    Drugs; 1994 Feb 05; 47(2):318-31. PubMed ID: 7512904
    [Abstract] [Full Text] [Related]

  • 32. [Inhaled corticosteroids: first-line therapy in asthma].
    Hajiro T, Ishihara K.
    Nihon Rinsho; 2001 Oct 05; 59(10):1967-72. PubMed ID: 11676140
    [Abstract] [Full Text] [Related]

  • 33. Clinical aspects of anti-inflammatory therapy in asthma.
    Kumar A, Busse WW.
    Curr Opin Pulm Med; 1996 Jan 05; 2(1):40-7. PubMed ID: 9363114
    [Abstract] [Full Text] [Related]

  • 34. Inhaled corticosteroids in childhood asthma: long-term effects on growth and adrenocortical function.
    Salvatoni A, Piantanida E, Nosetti L, Nespoli L.
    Paediatr Drugs; 2003 Jan 05; 5(6):351-61. PubMed ID: 12765485
    [Abstract] [Full Text] [Related]

  • 35. Effects of high-dose inhaled fluticasone propionate on the hypothalamic-pituitary-adrenal axis in asthmatic patients with severely impaired lung function.
    Lee DK, Bates CE, Currie GP, Cowan LM, McFarlane LC, Lipworth BJ.
    Ann Allergy Asthma Immunol; 2004 Sep 05; 93(3):253-8. PubMed ID: 15478385
    [Abstract] [Full Text] [Related]

  • 36. Reported adverse drug reactions during the use of inhaled steroids in children with asthma in the Netherlands.
    de Vries TW, de Langen-Wouterse JJ, van Puijenbroek E, Duiverman EJ, de Jong-Van den Berg LT.
    Eur J Clin Pharmacol; 2006 May 05; 62(5):343-6. PubMed ID: 16583230
    [Abstract] [Full Text] [Related]

  • 37. Systemic exposure and urinary cortisol effects of fluticasone propionate formulated with hydrofluoroalkane in 4- to 11-year-olds with asthma.
    Kim KT, Milgrom H, Yoon YK, Levy AL, Matz P, Welch MJ, Cahn A, Collins DA, Kathman S, Mehta R, Su SF, Kunka RL.
    J Clin Pharmacol; 2008 Jan 05; 48(1):108-16. PubMed ID: 18094223
    [Abstract] [Full Text] [Related]

  • 38. Inhaled fluticasone propionate: a review of its therapeutic efficacy at dosages < or = 500 microg/day in adults and adolescents with mild to moderate asthma.
    Jarvis B, Faulds D.
    Drugs; 1999 May 05; 57(5):769-803. PubMed ID: 10353302
    [Abstract] [Full Text] [Related]

  • 39. [Longitudinal growth in children with asthma treated with inhaled glucocorticoids].
    Gradman J, Wolthers OD.
    Ugeskr Laeger; 2006 Feb 27; 168(9):885-9. PubMed ID: 16513049
    [Abstract] [Full Text] [Related]

  • 40. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
    Galant SP, van Bavel J, Finn A, Gross G, Pleskow W, Brown A, Hamedani AG, Harding SM.
    Ann Allergy Asthma Immunol; 1999 Mar 27; 82(3):273-80. PubMed ID: 10094218
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.